logo

LYEL

Lyell Immunopharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
5.56 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is LYEL a Buy, Sell, or Hold?
  • Based on a composite score of 5.56/10, we rate LYEL as a Netural. Our analysis breaks down into 6.55/10 for Fundamentals, 5.40/10 for Technicals, and 5.13/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is LYEL fundamentally strong?
What is the current technical signals for LYEL?
What is the analyst consensus for LYEL?